. >> that movement collides with an opportunistic drug company in the form of purdue pharma. they see the opportunity to expand the use of these drugs beyond the cancer wards, kind of into the mainstream of medicine. and the drug that becomes the vehicle through which they do that is a drug called oxycontin. >> oxycontin is one of america's new prescription wonder drugs. it's a powerful painkiller... >> oxycontin was not really a new drug. the molecule had been around since 1916. what they did is they took this old, existing drug and they introduced a time-release mechanism into it so that it would be significantly less addictive because it wouldn't be released up front all at once. that's how they pitched it to the fda. >> purdue pharma marketed it to doctors who were prescribing drugs for all manner of ailments to common, ordinary folks who were not dying of cancer. to them, oxycontin initially looked like a godsend. it looked like this wonder drug. like, all of a sudden, we can give this, and we don't need to prescribe eight vicodin a day. >> there is no question that the

"members of the cbc pac board include daron watts, a lobbyist for purdue pharma, the makers of highlyddictive opioid oxycontin; mike mckay and chaka burgess, both lobbyists for navient, the student loan giant that was spun off of sallie mae; former rep. al wynn, d-md., a lobbyist who represents a range of clients, including work last year on behalf of lorillard tobacco, the makers of newport cigarettes; and william kirk, who lobbies for a cigar industry trade group on a range of tobacco regulations. and a significant percentage of the $7,000 raised this cycle by the cbc pac was donated by white lobbyists, including vic fazio, who represents philip morris and served for years as a lobbyist to corrections corporation of america, and david adams, a former clinton aide who now lobbies for wal-mart, the largest gun distributor in america." that is what lee fang wrote at the intercept. >> it also groups labor groups, labor organizations, includes the whole scenario of individuals here in washington. i think that is the point that hillary clinton was making last night. we and the congression

and believe it or not, purdue pharma wanted to get approval for 11-16-year-olds to get oxycontin. remember, this is a heroin equivalent. this would go to 11-16 yierlds. and what they decided to do was to not have any advisory panel at all on that issue in august of 2015. now, this despite the fact that it was controversial, that it had tremendous social gact impacimpact in our society, andt the f.d.a.'s own guidance says that advisory panels -- expert advisory panels are needed on drugs of that nature when pediatric dosing, child prescribing is in question. the f.d.a. just ignored it. then when i put my hold on dr. califf's nomination, senator manchin put his hold on, we're raising this issue. we're saying to the f.d.a., we need advisory panels. we need a change of culture at the f.d.a. this just can't continue. the f.d.a. said they will look at it. the f.d.a. said they would study it. and then the f.d.a. announce twad weeks ago, no -- announced two weeks ago, no advisory panels for any of the new opioids which are in the pipeline over at the f.d.a. because they are -- quote, unqu